A recent meta-analysis including 23 trials and 5543 patients found that administering prophylactic probiotic therapy demonstrated a 31% decreased risk for VAP among adult patients compared with placebo groups. No differences were seen between the groups in ICU/hospital 28- and 90-day mortality or incidence of wound infection, catheter-related bloodstream infection, bacteremia, ICU-acquired infections, diarrhea, infectious complications, and UTI.
Learn more about hospital-acquired infections.
This Rapid Review Quiz was excerpted and adapted from the Medscape articles: US Deaths from Antibiotic Resistant 'Superbugs' Rose 15% in 2020, Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia, Ventilator-Associated Pneumonia Overview of Nosocomial Pneumonias, Meropenem-Vaborbactam, Doripenem, and Hospital-Acquired Infections.
Lead Image: Pojoslaw/Dreamstime
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Rapid Review Quiz: Hospital-Acquired Pneumonia - Medscape - Sep 15, 2022.